Registration

Sign Up:

(*) denotes required form field(s)

WorkCast's registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Register  

Outcome studies to advance excellence in laboratory medicine


December 6th, 2023

[EST: 9:00 AM, CET 3:00 PM, CST 10:00 PM]

Laboratory professionals are now more than ever required to perform studies that provide evidence of the impact of testing on patient outcomes since the growth of laboratory medicine is reliant on its “value add” in the health-care landscape. In order to demonstrate the value for testing, we need to understand whether the test is worth of investment and to identify the impact of testing on management, care pathways and outcomes. However, in reality, to link the clinical laboratory information to value is challenging. Most laboratory tests are used for multiple purposes and in combination with other laboratory or medical tests in a complex care pathway. Impact of laboratory testing on patient outcomes is partial and variable since measured outcomes may be many steps beyond the performance of the test and affected by many other variables. So when the outcome information is missing, quantifying the value of the lab tests is difficult. The IFCC Task Force on Outcome Studies in Laboratory Medicine (TF-OSLM) was established in 2022. In this webinar, three members from the IFCC TF-OSLM will share the taskforce’s mandates and experience in identify existing peer reviewed, high quality publications that demonstrate the value of laboratory medicine in healthcare and developing a funded research program for investigators in hospitals located around the world to conduct new retrospective and prospective research with outcomes that assess the value of laboratory medicine in healthcare overall.


This webinar comprises of three following presentations of 20 min each followed by 20 min of panel discussion at the end.

Chair: Dr. Verena Gounden

Talk 1- "Quantifying the Advantage of Laboratory Medicine: Evidence from Clinical Outcomes" -  Prof. Zhen Zhao

Talk 2- "Timely cardiovascular marker results for getting clinical outcomes" - Dr. Claudio Suárez

Talk 3- "C-reactive protein and procalcitonin – Outcome studies for biomarker guided antibiotic therapy" - Dr. Erik Koldberg Amundsen


Please feel free to share this event in your social media with #IFCCLive Webinars.

Click here to convert to your time zone

Presenters:

Presenter
Dr. Verena Gounden
Head of the Chemical Pathology Department
National Health Laboratory Service and University of KwaZulu Natal, South Africa
Presenter
Prof. Zhen Zhao
Professor of Clinical Pathology and Laboratory Medicine
Weill Cornell Medicine, USA
Presenter
Dr. Claudio Suárez
Clinical pathologist
LaboratOp, Chile
Presenter
Dr. Erik Koldberg Amundsen
Medical doctor
Oslo University Hospital, Norway